Sustained activation of epidermal growth factor receptor in cholangiocarcinoma: a potent therapeutic target?
- 30 November 2004
- journal article
- editorial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 41 (5), 859-861
- https://doi.org/10.1016/j.jhep.2004.09.003
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Cholangiocarcinoma: Current concepts and insightsHepatology, 2003
- Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase–dependent pathway in ratsGastroenterology, 2002
- Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiologyJournal of Gastroenterology and Hepatology, 2002
- Functional heterogeneity of the intrahepatic biliary epitheliumHepatology, 2000
- Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell lineHepatology, 1999
- Bile acid feeding induces cholangiocyte proliferation and secretion: Evidence for bile acid–regulated ductal secretionGastroenterology, 1999
- Marked Elevation of Serum Interleukin-6 in Patients With CholangiocarcinomaAnnals of Surgery, 1998
- Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes.Gastroenterology, 1997
- Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes.American Journal of Physiology-Gastrointestinal and Liver Physiology, 1997
- CholangiocarcinomaAnnals of Surgery, 1996